Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Syndecan-1 Inhibitors

Common Syndecan-1 Inhibitors include, but are not limited to Curcumin CAS 458-37-7, Genistein CAS 446-72-0, Resveratrol CAS 501-36-0, Tunicamycin CAS 11089-65-9 and Thymoquinone CAS 490-91-5.

Syndecan-1 is one of the members of the syndecan family, which comprises transmembrane proteoglycans primarily found on the surface of cells. These proteoglycans have a conserved cytoplasmic domain, a transmembrane domain, and an extracellular domain that is modified with heparan sulfate (and sometimes chondroitin sulfate) chains. Syndecan-1, in particular, plays crucial roles in various cellular processes, including cell adhesion, proliferation, migration, and differentiation. The heparan sulfate chains present on Syndecan-1 can bind to a myriad of ligands, including growth factors, chemokines, and extracellular matrix components. This allows Syndecan-1 to modulate signaling pathways and to regulate cell behavior in response to changes in the cellular environment.

Syndecan-1 inhibitors are a class of molecules designed to specifically target and reduce the activity, expression, or interactions of Syndecan-1. These inhibitors may work through various mechanisms, such as disrupting the binding of ligands to the heparan sulfate chains of Syndecan-1, blocking its interactions with intracellular signaling partners, or downregulating its expression on the cell surface. By inhibiting the functions of Syndecan-1, these molecules can influence a wide range of cellular processes in which Syndecan-1 is involved. Given the diverse roles of Syndecan-1 in cellular physiology, the study of its inhibitors can provide insights into cellular signaling, tissue regeneration, angiogenesis, and other processes. Moreover, understanding the functions and mechanisms of Syndecan-1 inhibitors can be instrumental in elucidating the broader roles of proteoglycans in cell biology and tissue homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

As a tyrosine kinase inhibitor, Genistein might suppress pathways that induce Syndecan-1 expression, thereby reducing its levels.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin can inhibit N-linked glycosylation, which may lead to reduced post-translational modification and stability of Syndecan-1.

Thymoquinone

490-91-5sc-215986
sc-215986A
1 g
5 g
$47.00
$133.00
21
(2)

Thymoquinone has been suggested to down-regulate Syndecan-1, particularly in some cancerous cells.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

This compound inhibits MEK, potentially suppressing downstream pathways that might induce Syndecan-1 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a PI3K inhibitor, LY294002 could potentially down-regulate pathways leading to Syndecan-1 expression.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

By inhibiting the Hedgehog signaling pathway, Cyclopamine might reduce Syndecan-1 expression in certain contexts.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

This p38 MAPK inhibitor might suppress signaling pathways that enhance Syndecan-1 expression, leading to its down-regulation.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

By inhibiting the Notch signaling pathway, DAPT could potentially suppress Syndecan-1 expression in some cell types.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, might down-regulate pathways leading to increased Syndecan-1 expression, particularly in the context of cancer cells.